Invention Grant
- Patent Title: Inhibitors of meprin α and β
-
Application No.: US16094460Application Date: 2017-04-18
-
Publication No.: US10975019B2Publication Date: 2021-04-13
- Inventor: Michael Wermann , Mirko Buchholz , Hans-Ulrich Demuth , Daniel Ramsbeck , Dagmar Schlenzig , Stephen Schilling
- Applicant: Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung E.V.
- Applicant Address: DE Munich
- Assignee: Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung E.V.
- Current Assignee: Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung E.V.
- Current Assignee Address: DE Munich
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: EP16165804 20160418
- International Application: PCT/EP2017/059116 WO 20170418
- International Announcement: WO2017/182433 WO 20171026
- Main IPC: C07D207/16
- IPC: C07D207/16 ; C07C259/06 ; C07D317/58 ; C07D319/18 ; C07D317/64 ; C07C255/58 ; C07D213/36
Abstract:
The present invention relates to novel hydroxamic acid derivatives as inhibitors of meprin β and/or α, pharmaceutical compositions comprising such compounds, methods for treatment or prophylaxis of diseases or conditions, especially such that are related to meprin β and/or α, and compounds and pharmaceutical compositions for use in such methods.
Public/Granted literature
- US20190127317A1 NOVEL INHIBITORS OF MEPRIN ALPHA AND BETA Public/Granted day:2019-05-02
Information query
